能倍乐（Spiolto®Respimat®）可改善哮喘患者的呼吸症状

Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that causes shortness of breath and coughing. Helps open the airways so air can move in and out of the lungs more easily, helping adults with chronic obstructive pulmonary disease (COPD) breathe easier.

Clinical trial results show that the addition of Spiolto® Respimat® can improve respiratory symptoms in asthma patients compared with placebo. It can improve lung function and control asthma symptoms in children and adolescents regardless of the type of allergic asthma they have. Adult patients with symptomatic asthma experienced improved airway obstruction when adding Spiolto® Respimat® to treatment to improve respiratory symptoms compared with placebo, independent of body mass index (BMI). All analyzes showed that adding Spiolto® Respimat® to an ICS or ICS/LABA combination regimen to improve respiratory symptoms in asthma patients resulted in improvements in respiratory symptoms in patients with previously uncontrolled asthma symptoms.

In a Phase III clinical development program, patients whose asthma symptoms remained uncontrolled on daily maintenance therapy improved their respiratory symptoms with the addition of Spiolto® Respimat®. These data analyzes were presented at the American Thoracic Society (ATS) International Conference in Washington, D.C., USA. It can be seen from the test results that Spiolto® Respimat® can improve the patient's quality of life, reduce the patient's pain, and has a positive effect on the patient's condition. The launch of this drug has brought new treatment options to many asthma patients.

The above is an introduction to Spiolto® Respimat®. If patients want to know more drug information about Respimat (Spiolto® Respimat®) (such as precautions, drug prices, purchase channels, etc.), they can consult the medical companion travel service.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (if there are any errors or omissions, please help to correct them). It is only to provide information on the latest drugs on the market in the world and to help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended hot articles: